发明申请
- 专利标题： Therapeutic Agent for Keratoconjunctival Disorder
- 专利标题（中）： 角结膜疾病治疗剂
-
申请号： US12085214申请日： 2006-12-06
-
公开(公告)号： US20090270474A1公开(公告)日： 2009-10-29
- 发明人: Keiichi Shibagaki , Shin-ichiro Hirai , Masatsugu Nakamura
- 申请人： Keiichi Shibagaki , Shin-ichiro Hirai , Masatsugu Nakamura
- 优先权： JP2005-341712 20051206
- 国际申请： PCT/JP2006/324324 WO 20061206
- 主分类号： A61K31/4164
- IPC分类号： A61K31/4164 ; A61P27/02
摘要：
An object of the present invention is to discover a new use of eprosartan or a salt thereof. Eprosartan or a salt thereof exhibits an excellent improving effect in a corneal disorder model, and therefore is useful as a therapeutic agent for a keratoconjunctival disorder such as dry eyes, corneal ulcer, keratitis, conjunctivitis, superficial punctate keratopathy, corneal epithelial defects, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis and filamentary keratitis.
信息查询
